ASEPTIC PROCESSING, TODAY AND FUTURE
|
|
- Norma Gray
- 5 years ago
- Views:
Transcription
1 ASEPTIC PROCESSING, TODAY AND FUTURE Dublin, Ireland, 4 October 2018 Marco Delgado Rueda ALL RIGHTS RESERVED 2018 PAREXEL INTERNATIONAL CORP.
2 AGENDA Today s Reality and Needs Issues and Probable Causes Regulators Concerns Future Aseptic Processing and Facility Design 2018 PAREXEL INTERNATIONAL CORP. / 2 ALL RIGHTS RESERVED
3 TODAY S REALITY AND NEEDS Today s Reality Change / smaller batches: High volumes set ups not easily adjustable to low volumes; Biopharma, clinical batches, personalized medicine and gene therapy products as well as Start ups require small volumes Needs Traditional manufacturing Aseptic rooms (curtains, RABS ) Some still using manual and semiautomatic operations; e.g. visible particles inspections, set ups, filling Operator manual interventions Regulatory authorities concerned about public risk; more scrutiny, and challenge ANNEX 1, MRA US-EU, Russian, Chinese Flexibility; smaller batches, simple and quick set up changes, affordability for mass market Advancement of New Technologies New facility designs, new technologies to manufacture, fill, monitor, control and test Need to separate operators from process Improved facilities, processes, technologies, understanding, training Simplify operations to ensure compliance 2018 PAREXEL INTERNATIONAL CORP. / 3 ALL RIGHTS RESERVED
4 ISSUES AND POTENTIAL CAUSES Issues and Concerns Dirt, foreign material, visible particles, leaking, underfilling/ empty containers, cracks, microcracks, device/ injector system not fully working Sterility assurance concerns Cleaning/ potential of cross contamination Stability concerns Potential Causes Facility design, manufacturing process design Deficient processes, complexity in set ups/ operations Old technologies to manufacture, fill, monitor, control test Operators not separated from the process, interventions Poor understanding, poor training Poor validation support Poor quality system 2018 PAREXEL INTERNATIONAL CORP. / 4 ALL RIGHTS RESERVED
5 REGULATORS CONCERN; HOW MANUFACTURERS CLAIM TO REMAIN IN AN STATE OF CONTROL Sterility Assurance Data Governance Personnel Qualification, Validation Premises and Equipment Aseptic processing areas deficient in their design Facility and equipment are not designed or maintained to assure cleanliness Inadequate in process controls to prevent critical/ major defects Insufficient environmental/personnel monitoring and incomplete environmental and personnel monitoring investigations Media fills not being fully representative; interventions Lack of procedures to protect against microbiological contamination and its oversight Qualification/ certification of operations and operators; justification of access to Class A and B Poor aseptic behaviors 2018 PAREXEL INTERNATIONAL CORP. / 5 ALL RIGHTS RESERVED
6 FUTURE ASEPTIC PROCESSING AND FACILITY DESIGN Promote automation, isolation and robotics product understanding on the design phase robotic inspection systems and PAT Look for augmented reality, digitally controlled operations, advanced vision systems, process monitoring/ control in place Use big data and analytics to confirm processes are controlled, capable and robust 2018 PAREXEL INTERNATIONAL CORP. / 6 ALL RIGHTS RESERVED
7 FUTURE ASEPTIC PROCESSING AND FACILITY DESIGN Look to improve simplicity, reduce risk and improve control through new technological solutions Look To: Eliminate operators direct interventions in Class A Promote gloveless isolation Design simple set ups, minimal moving parts, minimal change overs to reduce particles automatized inspection processes in place Promote sterilization in place, close systems Promote Data Integrity through technological solutions 2018 PAREXEL INTERNATIONAL CORP. / 7 ALL RIGHTS RESERVED
8 REFERENCES Robotics Solve Aseptic Filling Challenges; Automated robotic arms manipulate nested trays and containers inside closed aseptic filling systems. Jun 20, By Jennifer Markarian. Equipment and Processing Report. Volume 11, Issue 7. Pharmatech.com vanrx.com/robotics-in-pharmaceutical-manufacturing. July 13, fedegari.com. Emerging Gloveless Robotic Technologies in Aseptic Manufacturing for Personalized. Cytotoxic Drugs. S. Mauri. Manager, BU Integrated Projects 2018 PAREXEL INTERNATIONAL CORP. / 8 ALL RIGHTS RESERVED
9 THANK YOU 2018 PAREXEL INTERNATIONAL CORP. / 9 ALL RIGHTS RESERVED
MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals
MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A
More informationMA/INS/GMP/735037/2014 Annex 1 of the GMP Guidelines on Good Manufacturing Practice - Manufacture of Sterile Medicinal Products
31 March, 2015 European Medicines Agency GMP/GDP Inspectors Working Group (GMP/GDP IWG) 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Subject: MA/INS/GMP/735037/2014 Annex 1 of the GMP
More informationWHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future. By: Hite Baker
WHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future By: Hite Baker August 2017 Introduction This Facility Focus Survey Report explores how to design sterile
More informationImportance of ICH Guidance in Fulfilling Process Validation Requirements
Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process
More informationFuture of Pharmaceutical Quality and the Path to Get There
Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,
More informationClaus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team
Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team
More informationTraining. Education CALENDAR FEDEGARI TECH CENTERS DM#407036
2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop
More informationICH Q8, 9 & 10 and the Impact on the QP
1 ICH Q8, 9 & 10 and the Impact on the QP Peter H. Gough David Begg Associates phg@david-begg-associates.com 2 A New Approach to Regulation Approach to the regulation of pharmaceuticals is undergoing a
More informationTraining Prospectus Public Course Dates
Training Prospectus 2018 Public Course Dates Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries, the Honeyman
More informationClaudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group
FDA Compliance and Regulatory Symposium Understanding the FDA s Latest cgmp Guidances: Opportunities and Pitfalls Claudio Pincus, President, The Group R. Owen Richards, President, Regulatory Services Daniel
More informationTerrence Tougas. Dennis Sandell
Terrence Tougas Boehringer Ingeheim, Ridgefield, CT Dennis Sandell S5 Consulting, Lund, Sweden (c) 2011 Sandell & Tougas 1 Transforming the general concept of Quality into objective, well defined and actionable
More informationPDA 71 Years of Connecting People, Science and Regulation
PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International
More informationValue Paper. Are you PAT and QbD Ready? Get up to speed
Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more
More informationPharmaceutical Manufacturing and Engineering Catalog Excerpt
Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical
More informationQ8 and Q8 annex An industry Perspective
Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference
More information2016 PDA Data Integrity Workshop
The Parenteral Drug Association presents the... 2016 PDA Data Integrity Workshop April 19-20 I London, UK September 14-15 I Washington, DC November 8-9 I Berlin, Germany December 7-8 I San Diego, CA WORKSHOP
More informationKeynote GMP & Validation from disaster, via overkill, to common sense.
Keynote GMP & Validation from disaster, via overkill, to common sense. Gordon Farquharson Melbourne - July 2016 1 My thoughts Power in the GMP world, leaders and followers. When validation became an industry.
More informationCDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
More informationOffice of Pharmaceutical Quality Key Quality Initiatives
Office of Pharmaceutical Quality Key Quality Initiatives Ashley B. Boam, MSBE Director Office of Policy for Pharmaceutical Quality Office of Pharmaceutical Quality Center for Drug Evaluation and Research
More informationTraining Prospectus Public Course Dates
Training Prospectus 2019 Public Course Dates Honeyman Group Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries,
More informationCURRICULUM VITAE. Environment, Occupational Health and Safety)
CURRICULUM VITAE PERSONAL INFORMATION Name DIMITRIU LAVINIA CRISTINA Nationality Romanian Date of birth 13 August 1957 Sex Employer / Field of activity WORK EXPERIENCE female Antibiotice Quality Unit 25
More informationQuality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
More informationChallenges of Implementation of ICH Q 8
Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated
More informationEU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does
More informationICH Q7 - API. Presented by Ashley Isbel 4 July, 2016
ICH Q7 - API Presented by Ashley Isbel 4 July, 2016 ICH Q7 ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (November 2000) Adopted or referenced by: PIC/S in 2007 - Guide
More informationTechnology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems
Technology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems A robust and secure manufactured product is the desired end result for pharmaceutical companies. Scale-up and
More informationECA. Avoiding Failures & Rejects in Parenteral Manufacturing September 2014, Copenhagen, Denmark. and beyond.
ECA ACADEMY Speakers Martin Dearden UCB Derek Duncan Lighthouse Dr Helmut Gaus Boehringer Ingelheim Al Goodwin Amgen Uli Kuchenbrod Vetter Pharma-Fertigung *New Programme* Image: Seidenader Dr Stephen
More informationKEY HIGHLIGHTS WORKSHOP 2019
KEY HIGHLIGHTS aenvironmental Monitoring afacility Design apractical Case Studies avisual Inspection aclean Room Behaviours aprocess Simulations arecent 483s, warning Letters and EU Observations WORKSHOP
More informationMere Hotel Golf & Spa Resort, Knutsford, UK VAT per delegate for two day attendance. PHSS Aseptic Processing Workshop Syndicates 2019
NEW ANNUAL EVENT 3rd & 4th April 2019 Mere Hotel Golf & Spa Resort, Knutsford, UK 700 + VAT per delegate for two day attendance over 25 years of advancing pharmaceutical and healthcare sciences PHSS Aseptic
More informationTechnically Unavoidable Particles Profile (TUPPs) Guide
Technically Unavoidable Particles Profile (TUPPs) Guide Priscilla Zawislak Global Regulatory Affairs Manager Ashland Inc. Chair Elect, IPEC-Americas pszawislak@ashland.com www.ipecamericas.org 1 Agenda
More informationNATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM
NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM Document No.GLP-102 Version/Issue No. 3 Issue Date: October, 2007 NATIONAL GLP COMPLIANCE MONITORING AUTHORITY DEPARTMENT
More informationQuality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development
Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com
More informationOffice of Pharmaceutical Quality: Why, What, and How?
Office of Pharmaceutical Quality: Why, What, and How? Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research NIPTE Annual Scientific Conference
More informationTimescales for Change A Look at Innovation in the Pharmaceutical Industry
Timescales for Change A Look at Innovation in the Pharmaceutical Industry 3rd FDA/PQRI Conference on Advancing Product Quality 23 Mar 2017 Robert F. Meyer, Ph.D. Global Pharmaceutical Commercialization
More informationHow CDER is Encouraging Adoption of Emerging Technologies in Pharmaceutical Industry
How CDER is Encouraging Adoption of Emerging Technologies in Pharmaceutical Industry Moderator: Lawrence Yu Speakers: Thomas O Connor & Sharmista Chatterjee Emerging Technology: A Key Enabler for Modernizing
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationIntroduction to STP (Clinical Science) Clinical Pharmaceutical Sciences
Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching
More informationQuality assurance in the supply chain for pharmaceuticals from the WHO perspective
1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation
More information2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More informationThe Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation
The Product Journey An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation This one day conference will be held on 16th September The conference day will include speakers from
More informationOSIsoft. Users Conference 2013
OSIsoft. Users Conference 2013 Pharmaceutical and Life Sciences: Towards a Recipe Driven Company and the Critical Role of the Real Time Infrastructure Continuous Process Verification By: Martin Browning,
More informationImpact of ICH Q9 and the application of Risk Management
Safeguarding public health Impact of ICH Q9 and the application of Risk Management An inspector s perspective on the impact on inspectional approaches and expectations Ian Thrussell Strategy and Development
More informationSymposium on Continuous Manufacturing of Pharmaceuticals Notes
1 2012 11 13 Symposium on Continuous Manufacturing of Pharmaceuticals Notes These are notes from the first open meeting regarding Novartis- MIT Center for Continuous Manufacturing (CCM). The meeting is
More informationThe Evolution of Technical Communication in Europe
The Evolution of Technical Communication in Europe AGORIA R&S Event 2015 Dr. Michael Fritz, Executive Director Dr. Claudia Klumpp, Standards (tekom Deutschland) 1 OUTLOOK Introduction Who we are What we
More informationJUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
More informationTowards malaria elimination: ADB-supported work at Myanmar FDA
Towards malaria elimination: ADB-supported work at Myanmar FDA Valerio Reggi 25 January 2018 Disclaimer: The views expressed in this paper/presentation are the views of the author and do not necessarily
More informationVetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018
Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service
More informationPDA: A Global. Association. Points to Consider in the. Manufacturing of Sterile Products
PDA: A Global Points to Consider in the Association Manufacturing of Gabriele Gori Global Head, GMP Compliance and Auditing Novartis Vaccines & PDA Task Force Co-Chair Disclaimer: The views and opinions
More informationImplementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
More informationProgress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003
Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared
More informationICH Q10 Pharmaceutical Quality System
Safeguarding public health ICH Q10 Pharmaceutical Quality System An EU Regulator s Perspective Presentation overview Why does Q10 exist and what were the desired outcomes Content of the Q10 step 2 document
More informationHiding In Plain Sight. How Ultrasonics Can Help You Find the Smallest Bonded Wafer and Device Defects. A Sonix White Paper
Hiding In Plain Sight How Ultrasonics Can Help You Find the Smallest Bonded Wafer and Device Defects A Sonix White Paper If You Can See It, You Can Solve It: Understanding Ultrasonic Inspection of Bonded
More informationForeign Particulate Matter testing using the Morphologi G3
Foreign Particulate Matter testing using the Morphologi G3 Introduction The Morphologi G3 with its Foreign Particle Detection capabilities allows the detection, enumeration and size classification of foreign
More informationOffice of Inspector General Update
Office of Inspector General Update 15th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 3, 2014 Mary E. Riordan, Senior Counsel Office of Counsel to the Inspector
More informationVisual Inspection PDA Europe Interest Group Meeting. 1 March 2016 Berlin Germany. The Parenteral Drug Association presents:
The Parenteral Drug Association presents: 2016 PDA Europe Interest Group Meeting Visual Inspection 1 March Interest Group Meeting 2-3 March Introduction to Visual Inspection 4 March Particle Identification
More informationProcedure for Obtaining Verification of a Stormwater Manufactured Treatment Device from New Jersey Corporation for Advanced Technology
Procedure for Obtaining Verification of a Stormwater Manufactured Treatment Device from New Jersey Corporation for Advanced Technology For use in accordance with the Stormwater Management Rules, N.J.A.C.
More informationREGISTER EARLY! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES SPECIAL DISCOUNTS AVAILABLE
A must attend GMP event for all pharmaceutical companies! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES 11 13 JUNE 2019 COPENHAGEN, DENMARK REGISTER EARLY! SPECIAL
More informationESL E-Learning for Business Consultants. A look into factory processes of the future. Muraishi Joanna
ESL E-Learning for Business Consultants A look into factory processes of the future Muraishi Joanna Here is the overview of this e-learning module: Module title A look into factory processes of the future
More informationEU, USA and Japan (II) Reports from Regulators on Exchange Assignments
EU, USA and Japan (II) Reports from Regulators on Exchange Assignments Yoshikazu Hayashi MHLW/PMDA Liaison at EMA PMDA 24th Annual EuroMeeting 26-28 March 2012 Copenhagen, Denmark Disclaimer The views
More informationManaging Risk in Aseptic Processing
The Parenteral Drug Association presents: 2015 PDA Europe Conference Managing Risk in Aseptic Processing 2 July Particle Identification in Parenterals One-Day Training Course 2 July Cleaning & Disinfection
More informationAssociation. Innovation in Medicines PDA: A Global. and Manufacturing. David Tainsh, GSK Keith Pugh, MHRA
Innovation in Medicines PDA: A Global and Manufacturing Association David Tainsh, GSK Keith Pugh, MHRA Joint Regulators/Industry QbD Workshop 28-29 January 2014 London, UK Introduction Current State We
More informationthe SPD company Dr Clive Simon, Principal, The SPD Company.
the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated
More informationREGISTER EARLY! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES SPECIAL DISCOUNTS AVAILABLE
A must attend GMP event for all pharmaceutical companies! ADVANCED GMPS AND CURRENT REGULATORY ISSUES WITH FDA AND OTHER REGULATORY AUTHORITIES 11 13 JUNE 2019 COPENHAGEN, DENMARK REGISTER EARLY! SPECIAL
More informationEUROPE March Brussels, Belgium CALL FOR ABSTRACTS. Join Us at the Crossroads of Healthcare. DIAglobal.org/Europe2020 #DIAEurope2020
EUROPE 2020 17-19 March Brussels, Belgium CALL FOR ABSTRACTS Join Us at the Crossroads of Healthcare I1 Steering Committee Francis Arickx INAMI, Belgium Matthieu Boudes EPF, Belgium Sini Eskola EFPIA,
More informationInternal Controls: The Basics National Grants Management Association May 17, 2017
Internal Controls: The Basics National Grants Management Association May 17, 2017 Page 1 Agenda Establish a fundamental understanding of internal control Describe the five components of internal control
More informationQuality by Design and OINDP. Today s Presentation
Quality by Design and OINDP Setting the Stage John C Berridge IPAC-RS September 2008 Today s Presentation QbD definition Setting the stage from an ICH perspective Future Opportunities 2 QbD Definition
More informationMedi-Plus In-Hospital. Sterilization Packaging
Medi-Plus In-Hospital Sterilization Packaging In-Hospital Sterilization Packaging Medi-Plus brand sterilization packaging is manufactured by, one of the largest manufacturers of medical grade pouches in
More informationSPONSORING PACKAGE 3D Medical Printing Conference &Expo. Perugia, Italy 7nd edition July 9 &
SPONSORING PACKAGE 3D Medical Printing Conference &Expo Perugia, Italy 7nd edition July 9 &10 2019 www.3dmedicalconference.com Sponsorship and exhibitor options Partnerships Facilities Start-Up*** Bronze
More informationBuilding Toward a Modern Pharmaceutical Manufacturing Sector: Encouraging Development and Adoption of Emerging Technology
Building Toward a Modern Pharmaceutical Manufacturing Sector: Encouraging Development and Adoption of Emerging Technology Sau (Larry) Lee, Ph.D. Associate Director for Science Office of Pharmaceutical
More informationNordson Closes the Case on Hot Melt Adhesive Sealing
Nordson Closes the Case on Hot Melt Adhesive Sealing Compared to Tape, Sealing with Hot Melt Adhesive Lowers Long-term Operational Costs Package sealing methods are all the same, right? Wrong! While both
More informationMastering Environmental Monitoring
pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org
More informationPLANET 6G series. Vision Inspection for. Tablet & Capsule. Next Generation
Vision Inspection for Tablet & Capsule Next Generation PLANET G series l PLANET G Vision Inspection Capability Free Shape Tablet Application Time Saving New Product Setup Rapid Changeover cgmp Design Enclony
More informationContinuous Manufacturing, Emerging Technology and the Office of Pharmaceutical Quality
Continuous Manufacturing, Emerging Technology and the Office of Pharmaceutical Quality ISPE Continuous Manufacturing Conference Baltimore, MD Robert Iser, M.S. Acting Director, Office of Process & Facilities
More informationThe Process Analytical Technology Initiative: PAT and the Pharmacopeias
The Process Analytical Technology Initiative: PAT and the Pharmacopeias Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science CDER, FDA EDQM Spring Conference, Cannes, 3-43 4 May 2004
More informationApplication of Visible-Residue Limit for Cleaning Validation Richard J. Forsyth and Vincent Van Nostrand By Richard J. Forsyth,Vincent Van Nostrand
October 2, 2005 Application of Visible-Residue Limit for Cleaning Validation Richard J. Forsyth and Vincent Van Nostrand By Richard J. Forsyth,Vincent Van Nostrand Pharmaceutical plants must have visually
More informationVoluntary Education Program Readiness (Force Education & Training)
U N I T E D S T A T E S D E P A R T M E N T O F D E F E N S E Voluntary Education Program Readiness (Force Education & Training) A Research Agenda for DoD Voluntary Education Programs that Supports Strategic
More informationNIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators
NIHR / Wellcome Trust King s Clinical Research Facility Guidance for Investigators Introduction The NIHR Clinical Research Facilities provide dedicated facilities to support the delivery of externally-funded
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationWHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.
WHITE PAPER FACILITY FOCUS: GMP Facility Modernization By: David M. Marks, P.E. July 2017 Introduction In recent years, intensified industry competition and cost pressures have renewed interest in modernizing
More informationSCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total
SCIENCE + BEAUTY Technical Expertise for the Beauty Industry 6 pages total We can help you with a single scientific requirement Or take a full 360 o approach An Experienced Partner Schoon Scientific is
More informationCorrelation of Wafer Backside Defects to Photolithography Hot Spots Using Advanced Macro Inspection
Correlation of Wafer Defects to Photolithography Hot Spots Using Advanced Macro Inspection Alan Carlson* a, Tuan Le* a a Rudolph Technologies, 4900 West 78th Street, Bloomington, MN, USA 55435; Presented
More informationPharma Clean Assurance Programme.
Pharma Clean Assurance Programme www.lcpackaging.com Cleaner, safer and sustainable 02 Innovative FIBC programme for premium pharma clean packaging The biggest challenge for the pharmaceutical industry
More informationNZ China EEEMRA. Topics:
NZ China EEEMRA Topics: Mutual Recognition Agreements (MRAs) China Compulsory Certification (CCC) system EEEMRA Advantages of the EEEMRA Beyond the EEEMRA Peter Morfee Principal Technical Advisor EnergySafety
More informationVENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA
WORLD COMPLIANCE SEMINARS SPEAKER:- BRIAN G. NADEL President of Brian G. Nadel, GMP Consulting, LLC. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017
More informationBrad Luke. Director Peddle Thorp Auckland
Brad Luke Director Peddle Thorp Auckland Site Observation and Practical Completion Preparation PEDDLE THORP Introduction Architects Agreement for Services. Observation Work Plans. Auckland Council Quality
More informationTEC NOTE #2 POLISHING TECHNIQUES FOR FIBER OPTIC CONNECTORS
TEC NOTE #2 POLISHING TECHNIQUES FOR FIBER OPTIC CONNECTORS Critical to proper polishing is the applied process--the technique--that results in meeting the various specifications. This TEC NOTE discusses
More informationOphthalmic Digital Health Areas
FDA Perspectives on Ophthalmic Mobile Medical Applications and Telemedicine Ronald Schuchard Center for Devices and Radiological Health Office of Device Evaluation Ophthalmic Digital Health Areas Software
More informationTechnical Documentation - Key pit falls
Technical Documentation - Key pit falls Itoro Udofia, PhD Global Head, Orthopaedic & Dental Devices Presented by Ibim Tariah Ph.D Technical Director Healthcare Solutions September 2012 TFD00101ENUK Overview
More informationJoint - Jobs, Enterprise and Innovation. Opening Statement. Brian Hogan Marine Survey Office. Date: 21 September 2017
Joint - Jobs, Enterprise and Innovation Opening Statement Brian Hogan Marine Survey Office Date: 21 September 2017 I thank the Chairman and Committee Members for inviting me here today. The issues which
More informationEN Official Journal of the European Union L 117/176 REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL.
Seite 1 von 176 5.5.2017 EN Official Journal of the European Union L 117/176 REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices
More informationHandling Precaution for Terminal and Connector
1 Handling Precaution for Terminal and Connector Handling Precaution for Terminal and Connector This manual is to describe basic precautions for use of terminal and connector in the following. Make use
More informationManufacturing and Cosmetic Inspection Specification
Document Reference: MISB-MACIS-Rev (1) Page 1 of 13 Manufacturing and Cosmetic Inspection Specification Revision Change History Rev No. Effective Date Affected Page Change Descriptions Prepared by Reviewed
More informationFSMA Update. Jennifer Thomas Interim Director for FSMA Operations Center for Food Safety and Applied Nutrition Food and Drug Administration May 2018
FSMA Update Jennifer Thomas Interim Director for FSMA Operations Center for Food Safety and Applied Nutrition Food and Drug Administration May 2018 Foundational Rules Regulation Final Rule Published Preventive
More informationMastering Environmental Monitoring
PDA Europe Training Course The Parenteral Drug Association presents: Mastering Environmental Monitoring 4-5 September 2018 Wattwil Switzerland Training & Education Program europe.pda.org PDA Education
More informationCLICK TO ADD TITLE [SPEAKERS NAMES]
CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors 10th Global Health Supply Chain Summit, Accra (Ghana); Nov 15-17, 2017 Pharmaceutical Manufacturing in Ghana Challenges and Potential
More informationMEDICAL DEVICES : Guidance document
EUROPEAN COMMISSION DG ENTERPRISE Directorate G Unit 4 - Pressure Equipment, Medical Devices, Metrology MEDICAL DEVICES : Guidance document MEDDEV 2.10-2 Rev. 1 April 2001 (NOTE: For attachment 1 to 4
More informationAnnual report of the Good Manufacturing and Distribution Practice Inspectors Working Group 2017
17 July 2018 EMA/INS/GMP/19273/2018 Committees and Inspections Annual report of the Good Manufacturing and Distribution Practice Inspectors Working 30 Churchill Place Canary Wharf London E14 5EU United
More informationTechnical information
Technical information 53245 Reuse of screws, bolts and nuts Screws, bolts and nuts are frequently reused for cost reasons, often from a lack of knowledge about the resulting hazards. The operators (employers)
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More information